Clinical Trials
46 trialsApixaban in Thrombocytopenia
Beth Israel Deaconess Medical Center
CATIQ P3
Quercis Pharma AG
Study Of Gemcitabine, Nab-paclitaxel, PEGPH20 and Rivaroxaban for Advanced Pancreatic Adenocarcinoma
Memorial Sloan Kettering Cancer Center
A Study to Compare Health Care Costs Between Apixaban and Low Molecular Weight Heparin in Patients With Venous Thromboembolism and Cancer
Pfizer
PROTINCOL
Galician Research Group on Digestive Tumors
TESEO
Fundación Sociedad Española de Oncologia Médica
Revlimid® Capsules Drug Use-results Surveillance (Relapsed or Refractory ATLL)
Celgene
Goal-directed vs Preemptive Tranexamic Acid Administration in Non-cardiac Surgery
Konkuk University Medical Center
CAT_PB
Lebanese University
Clearance Of Mucus In Stents (COMIS)
M.D. Anderson Cancer Center
EDOI
Gruppo Oncologico Italiano di Ricerca Clinica
Atrial Fibrillation and Cancer: a Nationwide French Cohort Study
University Hospital, Caen
A Safety and Efficacy of Pomalyst® Capsules Under the Actual Use in All Patients Who Are Treated With Pomalyst at a Dose of 1 mg, 2 mg, 3 mg, or 4 mg
Celgene
imPaCT-PRO
Institute of Molecular Medicine and Biomedical Research
Tranexamic Acid in Surgery of Advanced Ovarian Cancer
University Hospital, Linkoeping
NEOTHROCOVID
Centre Antoine Lacassagne
TOP-RCT
University of Aarhus
ENOXACARE
Les Laboratoires des Médicaments Stériles
CISTRON
Odense University Hospital
Prospective Evaluation of Efficacy and Safety of Fondaparinux in Surgical Cancer Patients, Risk Factors for Thromboembolism
Hellenic Society of Surgical Oncology
FIIT_Score
Centro Hospitalar de Vila Nova de Gaia/Espinho, E.P.E.
FICT
Diagnostica Stago R&D
PREDICARE
LEO Pharma
Aspirin and Compression Devices for VTE Prophylaxis in Orthopaedic Oncology
Ohio State University Comprehensive Cancer Center
Risk Factors for Developing a Blood Clot in Patients Who Are Undergoing Cancer Treatment for Newly Diagnosed Gliomas
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Fondaparinux in Preventing Blood Clots in Patients Undergoing Surgery for Gynecologic Cancer
Masonic Cancer Center, University of Minnesota
Biomarkers Related to Thrombosis in Patients With Newly Diagnosed Multiple Myeloma Receiving Chemotherapy
UNC Lineberger Comprehensive Cancer Center
Anticoagulation and Inferior Vena Cava Filters in Cancer Patients With a Venous Thromboembolism
Northwell Health
Gemcitabine With or Without Dalteparin in Treating Patients With Unresectable or Metastatic Pancreatic Cancer
University of Rochester
COPPVATS
Aarhus University Hospital
MVTEP
University Hospital, Brest
Long-term Active Surveillance Study for Oral Contraceptives (LASS)
Center for Epidemiology and Health Research, Germany
Pilot Safety Trial of Chemotherapy and Use of Heparin in Patients With Pancreatic Cancer
CONKO-Studiengruppe
Gemcitabine With or Without Dalteparin in Treating Patients With Locally Advanced or Metastatic Pancreatic Cancer
National Cancer Institute (NCI)
Warfarin in Preventing Blood Clots in Cancer Patients With Central Venous Catheters
National Cancer Institute (NCI)
Flavopiridol in Treating Patients With Recurrent or Metastatic Head and Neck Cancer
National Cancer Institute (NCI)
Incidence of Blood Clots in Patients Undergoing Chemotherapy for Solid Tumors
European Organisation for Research and Treatment of Cancer - EORTC
PAM07
GERCOR - Multidisciplinary Oncology Cooperative Group
Combination Chemotherapy Plus Warfarin in Treating Patients With Prostate Cancer
Memorial Sloan Kettering Cancer Center
Thromboembolic Complications Related to Asparaginase in Children With Acute Lymphoblastic Leukemia (ALL) Treated According to NOPHO ALL 2008
Oslo University Hospital
Heparin or M-EDTA in Preventing Catheter-Related Infections and Blockages in Patients at High Risk for a Catheter-Related Infection
M.D. Anderson Cancer Center
Prevention of Venous and Arterial Thromboembolism, in Cancer Patients Undergoing Chemotherapy, With a Low Molecular Weight Heparin (Nadroparin Calcium)
Italfarmaco
Dalteparin in Preventing Blood Clots in Patients With Lung Cancer
National Cancer Institute (NCI)
Heparin or Enoxaparin in Patients With Cancer
Northwestern University
Detecting Abnormal Blood Clotting in Patients With Metastatic Cancer Undergoing Surgery
National Cancer Institute (NCI)
Hypercoagulability and Thromboembolic Risk in Patients With Malignant Disease, Evaluated by Thrombelastograph (TEG®)
Rigshospitalet, Denmark